Остеопороз и остеопатии

Расширенный поиск

АЛЬФАКАЛЬЦИДОЛ - ПРЕПАРАТС МНОГОКОМПОНЕНТНЫМ ДЕЙСТВИЕМ,направленным на снижение риска переломов и предупреждение падений (обзор литературы)

Список литературы

1. American Geriatrics Society, British Geriatrics Society, American Academy of Orthopaedic surgeons panel on falls prevention. Guideline for the prevention of falls in older persons. // J. Am. Geriatr Soc, 2001, Vol.49, pp. 664-672

2. Birge S.J., Haddad J.G.: 25-Hydroxycholecalciferol stimulation of muscle metabolism. // J. Clin Invest, 1975, Vol. 56, pp. 1100-1107

3. Bischoff H.A., Borchers M., Gudat F. et al: Un situ detection of 1,25 dihydroxyvitamin D receptor in human skeletal muscle tissue. // Histochem, 2001, Vol.33, pp. 19-24

4. Bischoff-Ferrari H.A., Borchers M., Gudat F., Durmuller U. et al: Vitamin D receptor expression in human muscle tissue decreases with age. // J. Bone Miner Res, 2004, Vol. 19, pp. 265-269

5. Bishoff H.A., Stahelin H.B., Urscheler N. et al: Muscle strength in the elderly: its relation to Vitamin D metabolites. // Arch Phys Med Rehabil, 1999, Vol. 80, pp. 54-58

6. Black D.M., Steinbuch M., Palermo L., Dargent-Molina P., Lindsay R., Hoseyni M.S., et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporosis International, 2001;12:519-28

7. Boland R., de Boland A.R., Marinissen M.J. et al: Avian muscle cells as targets for the secosteroid hormone 1,25 dihydroxyvitamin D3. // J Mol Cell Endocrinol, 1995, Vol. 114, pp.1-8

8. Boland R.: Role of vitamin D in skeletal muscle function. // En- docr Rev, 1986, Vol.7, pp. 434-448

9. Bouxsein M.: Biomechanics of age-related fractures. In Marcus R., Feldman D., Kelsey J. (eds.) // Osteoporosis, second edition. Academic Press San Diego, pp. 509-534

10. Bouxsein M.L., Melton L.J., Rigs B.L., et al.: Age- and sex-specific differences in the factor of risk for vertebral fracture: a population-based study using QCT. // J. Bone Miner Res., 2006, Vol. 21, pp. 1475-1482

11. Campbell A.J., Robertson M.C., Gardner M.M. et al.: Randomized controlled trial of a general practice programme of home based exercise to prevent falls in elderly women. // British Medical J, 1997, Vol.315, pp. 1065-1069

12. Campbell A.J., Robertson M.C.: Implementation of multifactorial interventions for fall and fracture prevention. // J. Age and Ageing, 2006, Vol.35-S2, ii60-ii64

13. Campbell A.J., Spears G.F.S., Borrie M.J., Fitzgerald J.L.: Falls, elderly women and the cold. // Gerontology, 1988, Vol. 34, pp.205-208

14. Campbell A.J., Spears G.F.S., Borrie M.J.: Examination by logistic regression of the variables which increase the relative risk of elderly women falling compared to elderly men. [J. Clin Epidemiol., 1990, Vol. 43, pp. 1415-1420

15. Close J., Ellis M., Hooper R. et al.: Prevention of falls in the elderly trial (PROFET): a randomized controlled trial. // Lancet, 1999, Vol. 353, pp. 93-97

16. Costa E.M., Blau H.M., Feldman D.: 1,25-Dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. // Endocrinology, 1986, Vol. 119, pp. 2214-2220

17. Dukas L., Bischoff H.A., Lindpaintner L.S. et al.: Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. // J Am Geri- atr Soc, 2004, Vol. 52, pp. 230-236

18. Dukas L., Schacht E., Mazor Z., Stahelin H.B.: treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of < 5ml/min. // Osteoporosis International, 2005, Vol. 16, pp. 198-203

19. Dukas L., Shacht E., Bischoff H.A.: Better functional mobility in community dwelling elderly is related to D-hormone serum levels and to a daily calcium intake. // J. Nutrition Health and Aging, 2005, Vol.9, pp. 347-351

20. Dukas L.C., Schacht E., Mazor Z., Stahelin H.B.: A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65ml/min. // Osteoporosis International, 2005, Vol.16, pp.332-338

21. Egan M., Jaglal S., Byrne K. et al.: Factors associated with a second hip fracture: a systematic review. // J. Clinical Rehabilitation., 2007, Dec 5 epub ahead of print

22. Endo I., Inoue D., Mitsui T. et al.: Deletion of Vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. // J. Endocrinology, 2003, Vol. 144, pp. 5138-5144

23. Gallagher J.C., Fowler S.E., Detter J.R., Sherman S.S.: Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. // J. Clin Endocrinol Metab, 2001, Vol. 86, pp. 3618-3628

24. Gallagher J.C.: The effects of calcitriol on falls and fractures and physical performance tests. // J. Steroid Biochem Mol Biol, 2004, Vol. 89-90, pp. 497-501

25. Gerdhem P., Ringsberg K.A.M. et al.: Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA study of elderly women. // J. Osteoporosis International, 2005, Vol.16, pp.1425-1431

26. Greenspan S.L., Myers E.R., Maitland L.A. et al.: Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. // JAMA., 1994, Vol. 271, pp. 128-123

27. Helden S., Geel A.C., Geusens P.P. et al.: Bone and fall-related fracture risks in women and men with a recent clinical fracture. // J. Bone Joint Surg Am., 2008, Vol.90, pp.241-248

28. Holick M.F., Matsuoka L.Y., Wortsman J.: Age, vitamin D, and solar ultraviolet (letter) // J. Lancet, 1989, Vol. 2, pp. 1104-1105

29. IOF World Osteoporosis Days, Bangkok, Thailand, 2008, December 3-7

30. Ito M., Azuma Y., Takagli H. et al.: Curative effects of combined treatment with alendronate and 1a-Hydroxyvitamin D3 on bone loss by ovariectomy in aged rats. // Jpn J. Pharmacol, 2002, Vol. 89, pp. 255-266

31. Jackson C., Gaugris S., Sen S.S., Hosking D.: The effect of chole-calciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis // Q J Med, 2007, Vol.100, pp. 185-192

32. Janssen H.C.J.P., Samson M.M., Verhaar H.H.J.: Vitamin D deficiency, muscle function, and falls in elderly people // Am J Clin Nutr, 2002, Vol. 75, pp. 611-615

33. Jarvinen T.L.N., Sievanen H., Khan K.M. et al.: Shifting the focus in fracture prevention from osteoporosis to falls. // British Medical J., 2008, Vol.336, pp. 124-126

34. Kannus P., Niemi S., Parkkari et al. Why is the age-standardized incidence of low-trauma fractures rising in many elderly populations? J Bone Miner Res 2002, Vol. 17, pp.1363-1367

35. Kannus P., Sievanen H., Palvanen M. et al. Prevention of falls and consequent injuries in elderly people. Lancet 2005, Vol. 366 pp.1885-1893

36. Karkkainen M., Rikkonen T., Kroger H. et al.: Association between functional capacity tests and fractures: an eight-year prospective population-based cohort study. // Osteoporosis International, 2008, published ached of printing

37. Kenny R.A., Richardson D.A., Steen N. et al.: Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). // J. Am Coll Cardiol, 2001, Vol. 38, pp. 1491-1496

38. Kita K., Hujino K., Nasu T. et al.: A simple protocol for preventing falls and fractures in elderly individuals with musculoskeletal disease. // Osteoporosis Int, 2007, Vol. 18, pp. 611-619

39. Lau K.H.W., Baylink D.J.: Vitamin D therapy of osteoporosis: plain vitamin D therapy vs active vitamin D analog (D-hormone) therapy // Calcific Tissue International, 1999, Vol. 65, pp. 307-310

40. Leipzig R.M., Cumming R.G., Tinetti M.E.: Drugs and falls in older people: a systematic review and meta-analysis. // J. Psychotropic drugs. J Am Geriatr Soc, 1999, Vol.47, pp. 30-39

41. Link T.M., Majumdar S.: Current diagnostic techniques in the evaluation of bone architecture. // Current Osteoporosis report, 2004, Vol.2, pp. 47-52

42. Lips P.: Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implication. // Endocr Rew, 2001, Vol.22, pp. 477-501

43. Masoni A., Morosano M., Tomat M.F. et al.: Association between hip fractures and risk factors for osteoporosis. Multivariate analysis. // Medicina (B Aires), 2007, Vol. 67, pp. 423-428

44. McClung M.R., Geusens P., Miller P.D. et al.: Effect of risendronate on the risk of hip fracture in elderly women. // New England J Medicine, 2001, Vol. 344, pp. 333-340

45. Nakamura K., Oshiki R., Hatakeyama K. et al.: Vitamin D status, postural sway, and the incidence of falls in elderly community-dwelling Japanese women. // Arch Osteoporosis, 2006, Vol.1, pp. 21-27

46. Nevitt M.C., Cummings S.R.: Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. // J. Am Geriatr Soc, 1993, Vol.41, pp.1226-1234

47. NIH Consensus Development Panel. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-95

48. Nordin B.E.C., Need A.G., Morris H.A., Horowitz M.: The special role of «hormonal» forms of vitamin D in the treatment of osteoporosis. // Calcific Tissue International, 1999, Vol. 65, pp. 307-310

49. Ones K., Schacht E., Dukas L., Caglar N.: Effects of combined treatment with alendronate and alfacalcidol on bone mineral density and bone turnover in postmenopausal osteoporosis: a two-years randomized multiarm controlled trial. // The Internet J endocrinology, 2007, Vol.4, published online

50. Orimo H.: Clinical application of 1a(OH)D3 in Japan. // Aktuel Rheumatol, 1994, Vol. 19 (suppl), pp. 27-

51. Papadimitropoulos E., Wells G., Shea B. et al.: The osteoporosis methodology group, and the osteoporosis research advisory gropup. Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. // J. Endocrin Review, 2002, Vol. 23, pp. 560-569

52. Pfeifer M., Sinaki M., Geusens P. et al.: Musculoskeletal rehabilitation in osteoporosis: a review. // J Bone and Mineral Research, 2004, Vol. 19, pp. 1208-1214

53. Poole K.E., Compston J.E. Osteoporosis and its management. BMJ 2006, Vol. 333 pp.1251-1256

54. Province M.A., Hadley E.C., Hornbrook M.C., The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FISCIT trials. JAMA., 1995, Vol.273, pp.1341-1347

55. Richy F., Deroisy R., Lecart M.P. et al.: D-hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis. // Aging Ckin Exp Res, 2005, Vol. 17, pp. 133-142

56. Richy F., Dukas L., Schacht E.: Differential effects of D-Hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis. // Calcific Tissue International, 2008, epub ahead of print

57. Richy F., Ethgen O., Bruyere O., Reginster J.-Y.: Efficacy of alfacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. // Osteoporosis International, 2004, Vol.15, pp.301-310

58. Riggs B.L., Melton L.J., Robb R.A., Population based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. // J. Bone Mineral Research, 2004, Vol.19, pp.1945-1954

59. Ringe J.D., Farahmand P., Schacht E., Rozhnal A.: Superiority of a combined treatment of alendronate and alfacalcidol compared to the combination of alendronate and plain vitamin D or alfacalcidol alone in established postmenopausal or male osteoporosis. // Rheumatol Int., 2007, Vol. 27, pp. 425-434

60. Ringe J.D., Schacht E.: Prevention and therapy of osteoporosis: the respective roles of plain vitamin D and alfacalcidol. // Rheumatol Int, 2004, Vol. 24, pp. 189-197].

61. Robbins J., Aragaki A.K., Kooperberg C. et al.: Factors associated with 5-year risk of hip fracture in postmenopausal women. // JAMA., 2007, 2007, Vol.298, pp. 2389-2398

62. Robertson M.C., Delvin N., Gardner M.M., Campbell A.J.: Effectiveness and economic evaluation of a nurse delivered home exercise programme to prevent falls. 1: Randomised controlled trial. // British Medical J, 2001, Vol.322, pp. 697-701

63. Robertson M.C., Gardner M.M., Delvin N. et al.: Effectiveness and economic evaluation of a nurse delivered home exercise programme to prevent falls. 2: Controlled trial in multiple centres. // British Medical J., 2001, Vol. 322, pp. 701-704

64. Robinovitch S.N., Inkster L., Maurer J., Warnick B. Strategies for avoiding hip impact during sideways falls. J Bone Miner Res 2003, Vol.18, pp. 1267-1273

65. Sato Y., Manabe S., Kuno H., Oizumi K.: Amelioration of osteopenia and hypovitaminosis D by 1a-hydroxyvitamin D3 in elderly patients with Parkinson's disease. // J. Neurol Neurosurg Psychiatry, 1999, Vol.66, pp.64-68

66. Sato Y., Maruoka H., Oizumi K.: Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1a-hydroxyvitamin D3 and calcium supplementation. // J. Stroke, 1997, Vol. 28, pp. 736-739

67. Schacht E., Richy F., J.-Y. Reginster.: The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. // J. Musculoskelet Neuronal Interact, 2005, Vol. 5, pp. 273-284

68. Schacht E.: Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol. // Calcific Tissue International, 1999, Vol. 65, pp. 317-327

69. Sharla S.H., Schacht E., Bawey S. et al.: Pleiotropic effects of alfacalcidol in elderly patients with rheumatoid arthritis. // Arthritis + Rheumа, 2003, Vol. 23, pp. 268-274

70. Sorensen O.H., Lund B.I., Saltin B. et al.: Myopathy in bone loss of ageing: improvement by treatment with 1-alphahydroxycholecalciferol and calcium. // J. Clinical Science, 1979, Vol. 56, pp. 157-161

71. Stone K.L., Seeley D.G., Lui L.Y., Cauley J.A., Ensrud K., Browner W.S., et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res 2003 Vol 18, pp.1947-1954

72. Suzuki T., Kim H., Yoshida H., Ishizaki T.: Randomized controlled trial of exercise intervention for the prevention of falls in community-dwelling elderly Japanese women. // J. Bone Mineral Metabolism, 2004, Vol. 22, pp. 602-611

73. Swift C.C.: The role of medical assessment and intervention in the prevention of falls. // J. Age and Ageing, 2006, Vol.35-S2, ii65- ii68

74. Tinetti M.E., Baker D.I., McAvay G., et al.: A multifactorial intervention to reduce the risk of falling among elderly people living in the community. // New England J Medicine, 1994, Vol. 331, pp.821-827

75. US Department of Health and Human Services Bone Health and Osteoporosis: A Report of the Surgeon General US Department of Health and Human Services, Office of the Surgeon General, Rockville, MD, 2004

76. Verhaar H.J.J., Samson M.M., Jansen P.A.F. et al.: Muscle strength, functional mobility and vitamin D in older women. // Aging Clin Exp Res, 2000, Vol. 12, pp. 268-274

77. Wehrli F.W., Saha P.K., Gomberg B.R., et al.: Role of magnetic resonance for assessing structure and function of trabecular bone. // Top Magn Reson Imaging, 2002, Vol. 13, pp. 335-355

78. Wong M.: Raloxifene does not affect neuromuscular-related risk factors for falling or the incidence of falls in postmenopausal women with osteoporosis. // J. Am Geriatr Soc, 2000, Vol. 48, S44


Для цитирования:

., ., . АЛЬФАКАЛЬЦИДОЛ - ПРЕПАРАТС МНОГОКОМПОНЕНТНЫМ ДЕЙСТВИЕМ,направленным на снижение риска переломов и предупреждение падений (обзор литературы). Остеопороз и остеопатии. 2008;11(1):22-28.

For citation:

BELAYa Z.E., SOSUNOVA N.V., ROZhINSKAYa L.Y. AL'FAKAL'TsIDOL - PREPARATS MNOGOKOMPONENTNYM DEYSTVIEM,napravlennym na snizhenie riska perelomov i preduprezhdenie padeniy (obzor literatury). Osteoporosis and Bone Diseases. 2008;11(1):22-28.

Просмотров: 371

ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)